reports
Darden Restaurants Inc: 3 directors
Three Directors at Darden Restaurants Inc sold/sold after exercising options 22,463 shares at between 222.075USD and 223.777USD. The significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades...
- Jonathan Moreland
THOR Industries Announces Re-Authorization of $400 Million Share Buyba...
THOR Industries Announces Re-Authorization of $400 Million Share Buyback ELKHART, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors has retired the Company’s existing share repurchase authorization which was set to expire on July 31, 2025 and re-authorized the Company to repurchase up to $400 million of its Common Stock. The Company may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means. The timing and amount of any transactions will ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
RMAX RE/MAX HOLDINGS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
LOCO EL POLLO LOCO HOLDINGS INC
DIN DINE BRANDS GLOBAL INC.
MSGS MADISON SQUARE GARDEN SPORTS CORP. CLASS A
TCI TRANSCONTINENTAL REALTY INVESTORS INC
RDFN REDFIN CORPORATION
NANX NANOPHASE TECHNOLOGIES CORP.
BH BIGLARI HOLDINGS B
PAYS PAYSIGN INC
BBIO BRIDGEBIO PHARMA
VIAC VIACOMCBS INC. CLASS B
HIMS HIMS AND HERS HEALTH INC (A)
OSCR OSCAR HEALTH
LMND LEMONADE INC
ASTS AST SPACEMOBILE INC
SRM SRM ENTERTAINMENT INC
LGCY LEGACY EDUCATION INC.
BATRA LIBERTY MEDIA CORPORATION
OXOTECH OXO TECHNOLOGIES HLDG PLC
PHH PARK HA BIOLOGICAL TECHNOLOGY CO. LTD.
THOR Industries Announces Regular Quarterly Dividend
THOR Industries Announces Regular Quarterly Dividend ELKHART, Ind., June 18, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors approved, at its June 18, 2025, meeting, the payment of a regular quarterly cash dividend of $0.50 per share. The regular cash dividend is payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles. For more informati...
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(...
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grant of an option to purchase 75,000 shares of its common stock and restricted stock units coveri...
THOR Industries Announces Third Quarter Fiscal 2025 Results
THOR Industries Announces Third Quarter Fiscal 2025 Results CONTINUED EXECUTION OF KEY STRATEGIES LEADS TO STRONG QUARTER AS INITIATIVES BEGIN TO SHOW EFFECTS Fiscal 2025 Third Quarter Highlights ($ in thousands, except for per share data)Three Months Ended April 30, Nine Months Ended April 30, 2025 2024 Change 2025 2024 ChangeNet Sales$2,894,816 $2,801,113 3.3% $7,055,707 $7,509,241 (6.0)%Gross Profit$443,119 $421,852 5.0% $969,758 $1,050,631 (7.7)%Gross Profit Margin % 15.3% 15.1% +20 bps 13.7% 14.0% (30) bpsNet Income Attributable t...
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for ...
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair Based on market research, inguinal hernia repair is the most common type of hernia repair MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair. T...
TELA Bio Appoints Jeffrey Blizard as President
TELA Bio Appoints Jeffrey Blizard as President Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Jeffrey Blizard as President of TELA Bio, effective immediately. Mr. Blizard, who has served on TELA Bio’s Board of Directors for the past year, brings deep industry experience and proven leadership to this expanded role. “...
THOR Industries Announces Participation in Upcoming Investor Conferenc...
THOR Industries Announces Participation in Upcoming Investor Conference ELKHART, Ind., May 29, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the management team will be participating in an upcoming investor conference. THOR management will be hosting a fireside chat along with one-on-one meetings with analysts and institutional investors at the following event: Baird Global Consumer, Technology & Services Conference on June 5, 2025, in New York, NY. Management in attendance will include: Todd Woelfer, Senior Vice President & COO of THOR Industries, andSe...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Upgrading Consumer Discretionary (XLY) to Overweight A weak 20-year note auction last Wednesday sparked the first semi-meaningful pullback since this lockout rally began on April 22nd, which is when we turned short-term bullish (4/22/25 Compass) as the SPX was testing 5100-5120 support. We will be watching the 10- and 30-year Treasury yields closely, as both are approaching important resistance levels (more on that below). Unsurprisingly, SPX only tested short-term gap support on the pullback a...
THOR Industries Announces Date for its Fiscal 2025 Third Quarter Earni...
THOR Industries Announces Date for its Fiscal 2025 Third Quarter Earnings Release ELKHART, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that the date for its fiscal 2025 third quarter earnings release will be on Wednesday, June 4, 2025, before the market opens. Upon the release of THOR's fiscal 2025 third quarter earnings, the Company will concurrently publish a copy of the earnings release, a comprehensive question and answer document and a slide presentation on the Company's website. To view the quarterly earnings documents, please go to . A...
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Confer...
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 Jefferies Global Healthcare Conference. TELA’s management is scheduled to present at the 2025 Jefferies Global Healthcare Conference at 11:05 am ET on June 5th, 2025. Interested parties can access the live and archived webcast at . About TELA Bio, Inc.TELA Bio, ...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Darden Restaurants, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 8 May 2025 in which we reassessed the appropriateness of the ratings in the contex...
THOR Industries, Inc. Welcomes Seth Woolf to Executive Team
THOR Industries, Inc. Welcomes Seth Woolf to Executive Team ELKHART, Ind., May 13, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO), the world’s largest manufacturer of recreational vehicles, is pleased to announce that Seth Woolf has joined the company as Head of Corporate Development & Investor Relations. Mr. Woolf joins THOR in a strategic leadership role focused on supporting the development of long-term corporate initiatives and strengthening the Company’s capital markets communications. “Seth brings a unique and valuable combination of industry insight and financial exper...
- Wedbush Research
SHAK SHAKE SHACK INC. CLASS A
DEI DOUGLAS EMMETT INC
HPP HUDSON PACIFIC PROPERTIES INC.
XENE XENON PHARMACEUTICALS INC
WING WINGSTOP INC.
WEN WENDY'S COMPANY
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TXRH TEXAS ROADHOUSE INC.
TSLA TESLA INC
TRNO TERRENO REALTY CORPORATION
STKS ONE GROUP HOSPITALITY
STAG STAG INDUSTRIAL INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SBUX STARBUCKS CORPORATION
PZZA PAPA JOHN'S INTERNATIONAL INC.
PEGA PEGASYSTEMS INC.
OFC CORPORATE OFFICE PROPERTIES TRUST
MCD MCDONALD'S CORPORATION
JACK JACK IN THE BOX INC.
IMAX IMAX CORPORATION
EGP EASTGROUP PROPERTIES INC.
EAT BRINKER INTERNATIONAL INC.
DIN DINE BRANDS GLOBAL INC.
DENN DENNY'S CORPORATION
CTMX CYTOMX THERAPEUTICS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
CAKE CHEESECAKE FACTORY INCORPORATED
BXP BOSTON PROPERTIES INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
BJRI BJ'S RESTAURANTS INC.
FRX_CN FENNEC PHARMACEUTICALS
CMG CHIPOTLE MEXICAN GRILL INC.
DRI DARDEN RESTAURANTS INC.
WVE WAVE LIFE SCIENCES
PLYM PLYMOUTH INDUSTRIAL REIT INC.
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AAPL APPLE INC.
RCKT ROCKET PHARMACEUTICALS
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
YMAB Y-MABS THERAPEUTICS
TVTX TRAVERE THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
TNGX TANGO THERAPEUTICS
VERA INC
BROS VERA THERAPEUTICS INC
STRW DUTCH BROS INC
CAVA STRAWBERRY FIELDS REIT INC.
JBIO CAVA GROUP INC
JADE BIOSCIENCES
INC.
- Wedbush Research
SHAK SHAKE SHACK INC. CLASS A
WING WINGSTOP INC.
WEN WENDY'S COMPANY
TXRH TEXAS ROADHOUSE INC.
STKS ONE GROUP HOSPITALITY
SBUX STARBUCKS CORPORATION
PZZA PAPA JOHN'S INTERNATIONAL INC.
MCD MCDONALD'S CORPORATION
JACK JACK IN THE BOX INC.
EAT BRINKER INTERNATIONAL INC.
DIN DINE BRANDS GLOBAL INC.
DENN DENNY'S CORPORATION
CAKE CHEESECAKE FACTORY INCORPORATED
BJRI BJ'S RESTAURANTS INC.
CMG CHIPOTLE MEXICAN GRILL INC.
DRI DARDEN RESTAURANTS INC.
BROS DUTCH BROS INC
CAVA CAVA GROUP INC
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 6,600 shares of its common stock to twelve newly-hired employees, with a grant date of May 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuan...
TELA Bio Reports First Quarter 2025 Financial Results
TELA Bio Reports First Quarter 2025 Financial Results MALVERN, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Delivered revenue of $18.5 million in the first quarter 2025, representing growth of 12% over the prior year period and sequential growth of 5% over the fourth quarter of 2024;Increased demand for OviTex® and OviTex PRS Reinforced Tissue Matrix product...
TELA Bio to Announce First Quarter 2025 Financial Results
TELA Bio to Announce First Quarter 2025 Financial Results MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2025 financial results on Thursday, May 8, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. First Quarter Earnings Conference Call and Webcast DetailsInvestors...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.